0001144204-18-035971.txt : 20180627 0001144204-18-035971.hdr.sgml : 20180627 20180627101204 ACCESSION NUMBER: 0001144204-18-035971 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180626 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180627 DATE AS OF CHANGE: 20180627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KEWAUNEE SCIENTIFIC CORP /DE/ CENTRAL INDEX KEY: 0000055529 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] IRS NUMBER: 380715562 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-05286 FILM NUMBER: 18920738 BUSINESS ADDRESS: STREET 1: 2700 W FRONT ST CITY: STATESVILLE STATE: NC ZIP: 28677 BUSINESS PHONE: 7048737202 MAIL ADDRESS: STREET 1: P O BOX 1842 CITY: STATESVILLE STATE: NC ZIP: 28687-1842 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/ DATE OF NAME CHANGE: 19861216 FORMER COMPANY: FORMER CONFORMED NAME: KEWAUNEE MANUFACTURING CO DATE OF NAME CHANGE: 19680108 8-K 1 tv497213_8k.htm FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported) June 26, 2018

 

Kewaunee Scientific Corporation

 

(Exact name of registrant as specified in its charter)

     
Delaware 0-5286 38-0715562
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)

 

2700 West Front Street

Statesville, North Carolina

(Address of principal executive offices)

 

 

28677

(Zip Code)

 

Registrant’s telephone number, including area code    704-873-7202
           

 

N/A

(Former name or former address, if changed since last report.)

           

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
   
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
           

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
   
Emerging growth company ¨  
   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨   
     

 

 

 

 

 

Item 2.02Results of Operations and Financial Condition

 

On June 26, 2018, Kewaunee Scientific Corporation issued a press release announcing its financial results for the fourth quarter and year ended April 30, 2018. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

 

Item 9.01Financial Statements and Exhibits

 

(d)       Exhibits:

 

Exhibit No.   
    
99.1  Press Release of Kewaunee Scientific Corporation dated June 26, 2018

 

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

    (Registrant)
       Kewaunee Scientific Corporation
       
Date:  June 26, 2018      /s/ Thomas D. Hull III
     

Thomas D. Hull III

Vice President, Finance

      Chief Financial Officer

 

EX-99.1 2 tv497213_ex99-1.htm EXHIBIT 99.1
 
Exhibit 99.1
 

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

STATESVILLE, N.C., June 26, 2018 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2018.

Full Year, Fiscal Year 2018 Results:

  • Record sales of $158,050,000, an increase of 14.1% from the prior year.
  • Record pre-tax earnings of $9,480,000, an increase of 40.5% from the prior year.
  • Record net earnings of $5,188,000, an increase of 14.9% from the prior year which includes an unfavorable impact of $1,329,000 of additional tax expense recorded in the year to account for the implementation of the Tax Cuts and Jobs Act enacted on December 22, 2017. 
  • Record diluted earnings per share of $1.87, an increase of 12.7% from the prior year, which includes an unfavorable impact of $0.48 per diluted share of additional tax expense recorded in the year to account for the implementation of the Tax Cuts and Jobs Act enacted on December 22, 2017. 
  • Record order backlog of $116,335,000 at April 30, 2018, an increase of 2.5% from the prior year.

Fourth Quarter, Fiscal Year 2018 Results:

  • Sales of $44,508,000, an increase of 28.7% from the prior year fourth quarter.
  • Pre-tax earnings of $2,456,000, an increase of 34.5% from the prior year fourth quarter.
  • Net earnings of $1,433,000, an increase of 3.2% from the prior year fourth quarter.
  • Diluted earnings per share of $0.52, an increase of 2.0% from the prior year fourth quarter.

Record sales of $158,050,000 were delivered during fiscal year 2018, an increase of 14.1% from sales of $138,558,000 in the prior year. Domestic sales for the fiscal year were $114,594,000, an increase of 1.3% from sales of $113,081,000 in the prior year. International sales for the fiscal year were $43,456,000, an increase of 70.6% from sales of $25,477,000 in the prior year. Sales for the fiscal year ended April 30, 2018 reflect continued strength for Kewaunee's laboratory, healthcare, and technical furniture products in the US, Middle East, Indian, and Asian markets.

Pre-tax earnings for the fiscal year were $9,480,000, an increase of 40.5% compared to $6,746,000 for the prior period. Net earnings increased 14.9% for the fiscal year to $5,188,000, or $1.87 per diluted share, as compared to net earnings of $4,515,000, or $1.66 per diluted share, for the year ended April 30, 2017. These results reflect the aforementioned unfavorable impact of $1,329,000, or $0.48 per diluted share, of additional tax expense recorded in the fiscal year.

The order backlog was $116.3 million at April 30, 2018, a record, up from $116.1 million at January 31, 2018, and $113.5 million at April 30, 2017. Incoming orders continued to be strong in all of our key markets, increasing the order backlog to record levels.

Unrestricted cash on hand at April 30, 2018 was $9,716,000, as compared to $12,506,000 at April 30, 2017, and working capital was $35,942,000, as compared to $32,885,000. Short term debt was $5,052,000 at April 30, 2018, as compared to $4,509,000 at April 30, 2017, and total debt was $6,316,000 as compared to $6,940,000. The debt-to-equity ratio at April 30, 2018 was .10-to-1, as compared to .20-to-1 at April 30, 2017.

"The fourth quarter was an excellent quarter for the Company," said David M. Rausch, Kewaunee's President and Chief Executive Officer. "Our sales and pre-tax profit performance for the quarter were very strong in a very competitive laboratory furniture marketplace."

"Fiscal year 2018 was another year of growth for Kewaunee as we achieved record sales and pre-tax earnings for the fourth year in a row," said David M. Rausch. "Kewaunee's world class global sales network continues to focus on providing the highest quality products and services to our customers."

"Coming off four strong years, I remain optimistic about Kewaunee's future and anticipate sales and earnings growth in fiscal year 2019. The pace of activity, both domestically and internationally, remains solid as customers are investing in projects that require the products and services we provide."

About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Products include steel, wood, and laminate casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin worksurfaces and sinks.

The Company's corporate headquarters are located in Statesville, North Carolina. Direct sales offices are located in the United States, India, Singapore, and China. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company's China headquarters and sales office are located in Shanghai, China. Kewaunee Scientific's website is located at http://www.kewaunee.com.

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described in the forward-looking statements. Additional information concerning these factors is contained in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Thomas D. Hull III
704/871-3290

Kewaunee Scientific Corporation

Consolidated Statements of Operations

(in thousands, except per share data)














Three months ended


Years ended




 April 30,


 April 30,




2018


2017


2018


2017




(Unaudited)


(Unaudited)



Net sales



$    44,508


$    34,579


$ 158,050


$ 138,558

Cost of products sold


35,574


27,247


126,030


111,951

Gross profit



8,934


7,332


32,020


26,607

Operating expenses


6,574


5,581


22,934


20,065

Operating earnings


2,360


1,751


9,086


6,542

Other income


169


138


693


496

Interest expense


(73)


(63)


(299)


(292)

Earnings before income taxes


2,456


1,826


9,480


6,746

Income tax expense


966


431


4,115


2,126

Net earnings



1,490


1,395


5,365


4,620

Less: net earnings attributable to









    the noncontrolling interest


57


7


177


105

Net earnings attributable to 









    Kewaunee Scientific Corporation


$      1,433


$      1,388


$      5,188


$      4,515











Net earnings per share attributable to









    Kewaunee Scientific Corporation stockholders







       Basic



$        0.53


$        0.51


$        1.91


$        1.67

       Diluted



$        0.52


$        0.51


$        1.87


$        1.66











Weighted average number of common









shares outstanding









       Basic



2,728


2,712


2,720


2,705

       Diluted



2,795


2,734


2,777


2,726






















Kewaunee Scientific Corporation




Condensed Consolidated Balance Sheets




(in thousands)


















 April 30,


April 30,








2018


2017



Assets





(Unaudited)





Cash and cash equivalents




$      9,716


$    12,506



Restricted Cash




1,242


1,435



Receivables, less allowances




32,660


29,889



Inventories





17,662


14,935



Prepaid expenses and other current assets




2,224


1,047



    Total Current Assets




63,504


59,812



Net property, plant and equipment




14,661


14,027



Other assets





6,193


7,077



Total Assets





$    84,358


$    80,916













Liabilities and Equity









Short-term borrowings and interest rate swaps



$      3,885


$      3,591



Current portion of long-term debt




1,167


918



Accounts payable




14,754


11,995



Other current liabilities




7,756


10,423



    Total Current Liabilities




27,562


26,927



Other non-current liabilities




9,275


10,732



    Total Liabilities




36,837


37,659



Noncontrolling interest




462


374



Kewaunee Scientific Corporation equity




47,059


42,883



    Total Equity




47,521


43,257



Total Liabilities and Equity




$    84,358


$    80,916




GRAPHIC 3 kewlogo.jpg GRAPHIC begin 644 kewlogo.jpg M_]C_X 02D9)1@ ! 0( =@!V #_[0'(4&AO=&]S:&]P(#,N, X0DE-! 0 M :P< @4 )$ME=V%U;F5E(%-C:65N=&EF:6,@0V]R<&]R871I;VX@3&]G M;QP"#P #02!&' (4 -(14$< AD !DA%04Q42!P"'@ (,C Q-C S,#$< B@ M7%-%12!35$]262 R,#$V,#(R.2\S,S@W,#!,3T=/+"!-32 H,3(U,#"UD969A=6QT(CY+ M97=A=6YE92!38VEE;G1I9FEC($-O&UL;G,Z M97AI9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\B/@T*(" @(" @ M(" @(" @/&5X:68Z4&EX96Q81&EM96YS:6]N/C$Q-C(\+V5X:68Z4&EX96Q8 M1&EM96YS:6]N/@T*(" @(" @(" @(" @/&5X:68Z4&EX96Q91&EM96YS:6]N M/C$T,# \+V5X:68Z4&EX96Q91&EM96YS:6]N/@T*(" @(" @(" \+W)D9CI$ M97-C&UP;65T83X-"@T* M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TB=R(_/O_; M $, ! (# P,"! ,# P0$! 0%"08%!04%"P@(!@D-"PT-#0L,# X0%!$.#Q,/ M# P2&!(3%187%Q<.$1D;&18:%!87%O_; $,!! 0$!04%"@8&"A8/# \6%A86 M%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86 M%O_ !$( 9 !3 ,!(@ "$0$#$0'_Q = $ @,! 0$! !P@$ M!@D% 0(#_\0 9Q 0(% 00$!P<,#0<)!P4 0(# 0%!A$'"!(A,0D305$4 M(F%Q=8&S,C>SGGR.Y5Y(/A"$= M"WX0A" 0A" 1G6O]L],^?,>U3&#&=:_VSTSY\Q[5,6GWH?'$7O\\4:Z3/W\:1]SS?MWHVEH?SK3V3X/%^D?[">V%*[4"#Q0SGDGL+G(W;8D$2DDP,GXSCRSS<<5S4L]I/F& M (S[7HE)MN@RM%HD@Q(4^2;#6^H_$;!YJ/F&3&H,\S^]F->NN>#;CBCSGIGZALS(='ZJ* MZ;.'IX=VK9L\NB/_ &7LZQ:B6UIM:;E;N*:W HDF*$Z)"FM*/4RJ2^U_.6>U9Y\A@<(K)JA?%QZ@78 M]<%S3QF)ESQ6FT\&I9O.0VVGXJ1])/$DF)DZ-GW[*MZ <]NU&'1C*KV(IBG9 M2W7=T.L91H_B;]_55?FGCW4[8V1YRN#J9=M(L6Q*E==<<6B1IC!=<#:=YQPY M 2V@=JU**4@=I(B"ZY?6I,S< E:_=-9M2I.R#=23;MK6<:R[(2SBE);,U,+0 ML*<)0H*2A*0", GG&[;:W:B>YH]JM55U^AT2Z*I3J[2KJ0Z+:NF0E%2B9MYK/6RDU+*)ZF8 2HC! MPK=4,)(Q$UQ6+=MR;LO1BT;.3434)V[D5UYJH\9^6$NMYR?=F. W5!U:FR0 MDE0">&(LZ.4 A"$ A"$ A"$ A"$ A"$ A"$ A"$ BA?2$_"-?]$RGZ2+Z10O MI"?A&O\ HF4_21PB\O?YXHU MTF?OXTC[GF_;O1M+0_G6GLGP>+](_P!A/;"N<(0C;K79"$(!"/K:%..)0A*E M*40E*4C))/ 7DY1J5E66V&&4!MIIM(2AM(& E(' M#L$?TX)3PBN^UAM&2MGB8M*R'V9JX<%N:G!A;5-/:.Y;ODY)[K:VCNC=R]6I3.6Y1)'!Q_'(=H1S5Y!QBBEVUZL7/<,U7:]4'I^H3B]YY]TY*NX <@ MD#@$C@!RC$J,W-3\^]/3TR[,S4RX7'GWEE:W5DY*E*/$DQ_&,.Q&)KO3MXNA MZ/T;T8PN26?T_JNS[U7E'1'CO(L-T;/OV5;T Y[=J*\Q8;HV??LJWH!SV[43 M"F',.)[OG"[C[3;S*V7D)<;<24K0H9"@>!!!YB(M9T7-#<<:T_U!NBS MZFM"LVHSE9;F:C6 M:]4D)1/5NL3/A$X^A/%+>]@);;!XA"$I3Y,QN4(0"$(0"$(0"$(0"$(0"$(0 M"$(0"$(0"*%](3\(U_T3*?I(OI%"^D)^$:_Z)E/TD<',>0^+//9SSY'F?/F/:IC!C.M?[9Z9\^8]JF+3[T/CB.1K[)\'5 M/O\ /%&NDS]_&D?<\W[=Z+R]_GBC729^_C2/N>;]N]&TM#^=:>R?!XOTC_83 MVPKG"$(VZUV1DT>GS]6JLO3*9)OSDY-N!J7EV$%;CJSR2D#F8S;'MFN7?<\K M;]N4YV?J$VK#;+8Y#M4H\DI',J/ 1?O9>T%H>E=+349LM5*YIEK=F9_<\5@$ M<6F >*4]ZO=*[<# '19WGMC++>J=MR>*GSGHAVV5Y5=QU>S91''/IUM;V2]G M"1L-#%U7BTQ/7.4A;#/!;-,S\GL4[WKY#DGO-A"4H1DD <23'\:C.2E/D7I MV=F6I:6EVRX\\ZL(0VD#)4I1X #OBE>U?M&35XKF;3LB8=E;>R6YJ=3E#M2' M:!VH:\G-7;@<#IS-,TNWKDW\15KJGZU1T0V_HQHM>Q]R,-@Z=5,>]5/%'7/3 M/1'DVC:QVE3X:+.'C;OF>.9Z_*-Q"$(^+N2+#=&S[]E6] .>W: MBO,6&Z-GW[*MZ <]NU'(PG+TL;TPYAQ/=\X7>A"$9(\UD(0@$(0@$(0@$(0@ M$(0@$(0@$(0@$(0@$4+Z0GX1K_HF4_21?2*%](3\(U_T3*?I(X.8\A\6>>SG MGR.Y5Y(/A"$="WX0A" 0A" 1G6O]L],^?,>U3&#&=:_VSTSY\Q[5,6GWH?'$ M7O\\4:Z3/W\:1]SS?MWHVEH?SK3V3X/ M%^D?[">V%UL]: M07)JO7A3TTYC!<<5\91^@#@ !&9Y_I);R^)LV?U7?E';U]3&SU>-L_:0VSI1;/@5);\)J,PD&H5-U #LRH=G\1 /) X=IR0 XD\!'G:HWS;FG]JO5^Y9Y,M+-^*VA(WG9A MS'!MM/QE'\',X'&*"[0>L%QZJW#U\\I4G1Y59-/I;:\H9'+?6?CN$EC> MF',.)[OG"[T(0C)'FLA"$ A"$ A"$ A"$ A"$ A"$ A"$ A"$ BA?2$_"-?] M$RGZ2+Z10OI"?A&O^B93])'!S'D/BSSV<\^1W*O)!\(0CH6_"$(0"$(0",ZU M_MGIGSYCVJ8P8SK7^V>F?/F/:IBT^]#XXCD:^R?!U3[_ #Q7?:*T,JFK.T32 MYZ:>73[:D**TW.S:<=8\OKG5=2T/E8(RH\$@]IX18D=OGA@1FN"QM[!W/M;, MZJM4QKZ-;R+B<+;Q-' N;8UZ_P"GDV3;5$M&VY:@V]3F9"GRB-UIEH]*4Y*\!L'DZ\1Q2CR5SS-P7'4')V?FC MX[B^"4)[$(3R2@=B1^/C'48S'<"9VZZI^MK86B.A5W,YIOXB.!8CX35U1T1T MS\(ZO3U@U#N74FZUURXYK>*EC>F',.)[OG"[T(0C)'FLA"$ A"$ A"$ A"$ A"$ A"$ A M"$ A"$ BA?2$_"-?]$RGZ2+Z10OI"?A&O^B93])'!S'D/BSSV<\^1W*O)!\( M0CH6_"$(0"$(0",ZU_MGIGSYCVJ8P8SK7^V>F?/F/:IBT^]#XXCD:^R?!U4' M;YXAO; U@J.EUKRS-%I+SU3JV\B6GGF2925(YE1Y*<[4H[>9X#!F0=OGCRKS MMRBW9;DS0K@I[,]3YM&ZZRZ.![B#S2H'B".(/*,GN1551,4SJEY;RV]AK&+M MW,5;X=N)VTZ]6OZZ-_$Y>5NI5"LU>9JM5G7YV=FW"[,3#Z]Y;JCVD_\ YCD( MQ8EW:$1%&-7**Z*IIKXW MIK+,?A,=A:+V$JB:-VK=U:MVKH(0A'X=@0A" 0A" 0A" 18;HV??LJWH!SV[ M45YBPW1L^_95O0#GMVHY&$Y>EC>F',.)[OG"[T(0C)'FLA"$ A"$ A"$ A"$ M A"$ A"$ A"$ A"$ BA?2$_"-?\ 1,I^DB^D4+Z0GX1K_HF4_21P/(-TT(7L;174&D5GP(3R)19PMQ@J4G?1GW6"D@XXCAG@8] M?O\ /%).D9J4_1]HBWZI2IQZ2G9.AM.R\PPLH<:6'WL%)$9]D^7?B&)^[\+5 M,Q,Q/7#Q]F6-^YV/MM6N-<:^Q=.K2$G5*:_3ZA*LS4K,MEMYAY 6AU!&"E0/ M @Q2?:NV=9RR')BZK-9>G+;)*YB5&5NTS^];7\;FGMX<8F'9,VC9#4!MBUKM M<9D+H2G=:<&$,U/':CL2YWH[>:>T"?G4)<;*5)"DJ&"".!$=?FF57+-R;&(I MU51]:XZ89'HQI5>R^Y&)P=6NB?>IGBGMZ)C=/C#D_"+4[66S6J6,S>.G$B5- M<79^B,IR4=I8/-\-%_#5=L;XGHGUW MD(0CXNX(0A (0A (L-T;/OV5;T Y[=J*\Q8;HV??LJWH!SV[4?([E7D@^$(1T+?A"$(!"$(!&=:_VS MTSY\Q[5,8,9UK_;/3/GS'M4Q:?>A\<1R-?9/@ZI]_GBC729^_C2/N>;]N]%Y M>_SQ1KI,_?QI'W/-^W>C:6A_.M/9/@\7Z1_L)[85U9<<:=2ZTM2'$*"D+0HA M22#D$$<00>V+B[)&TXFI*E;,U)G4HGCAJ0K3J@E,R>0;?/)*^P+Y*[<'B:<0 M_OC9.:Y3A\RL_9W8VQQ3OCZZ&%8#,+V"N<.W.S?&Z77 *&2(KEM8[.$O=(F M;OL.6:EJZ:FNY7-/;E/*Z4H^S-2KPQ_*+[[4V@5)U)DG*Y1>IIUT,H\1\C#4\ .#;V M.WL"^8Y'(Y47N>BU:W:]-46N2#\C4)->X_+O)PI!_O!Y@C@1Q$8=B,-79JV\ M72](:.:3X3.K&NC]-R/>IWQUQTQ]2P(0A'&9*0A" 18;HV??LJWH!SV[45YB MPW1L^_95O0#GMVHY&$Y>EC>F',.)[OG"[T(0C)'FLA"$ A"$ A"$ A"$ A"$ M A"$ A"$ A"$ BA?2$_"-?\ 1,I^DB^D4+Z0GX1K_HF4_21PB\O?YXHUTF?OXTC[GF_;O1M+0_G6GLGP>+] M(_V$]L*YPA"-NM=@YQ.>REM#533:::MZX5/U"U5KP$#QWJ:2>*FN]':6_6G! MX&#(1P\=@;&-LS9OTZXGY=<.3A<5=PMV+EJ=4NLEM5FEW!0Y6LT6>8GI"=;# MLO,,+WD.)/:#^,

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